- Home
- ANIK vs ANEB Comparison
ANIK vs ANEB Comparison
Compare ANIK & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIK
- ANEB
- Stock Information
- Founded
- ANIK 1983
- ANEB 2020
- Country
- ANIK United States
- ANEB United States
- Employees
- ANIK N/A
- ANEB N/A
- Industry
- ANIK Medical/Dental Instruments
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- ANIK Health Care
- ANEB Health Care
- Exchange
- ANIK Nasdaq
- ANEB Nasdaq
- Market Cap
- ANIK 133.1M
- ANEB 111.8M
- IPO Year
- ANIK 1993
- ANEB 2021
- Fundamental
- Price
- ANIK $10.01
- ANEB $2.34
- Analyst Decision
- ANIK Buy
- ANEB Buy
- Analyst Count
- ANIK 1
- ANEB 2
- Target Price
- ANIK $16.00
- ANEB $8.00
- AVG Volume (30 Days)
- ANIK 127.3K
- ANEB 17.9K
- Earning Date
- ANIK 11-05-2025
- ANEB 11-13-2025
- Dividend Yield
- ANIK N/A
- ANEB N/A
- EPS Growth
- ANIK N/A
- ANEB N/A
- EPS
- ANIK N/A
- ANEB N/A
- Revenue
- ANIK $112,806,000.00
- ANEB N/A
- Revenue This Year
- ANIK N/A
- ANEB N/A
- Revenue Next Year
- ANIK $4.57
- ANEB N/A
- P/E Ratio
- ANIK N/A
- ANEB N/A
- Revenue Growth
- ANIK 30.55
- ANEB N/A
- 52 Week Low
- ANIK $7.87
- ANEB $0.80
- 52 Week High
- ANIK $18.37
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- ANIK 58.60
- ANEB 34.15
- Support Level
- ANIK $9.41
- ANEB $2.32
- Resistance Level
- ANIK $10.30
- ANEB $2.48
- Average True Range (ATR)
- ANIK 0.38
- ANEB 0.09
- MACD
- ANIK 0.01
- ANEB -0.04
- Stochastic Oscillator
- ANIK 43.70
- ANEB 0.00
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.